Contact us 24/7

Xarelto

Xarelto and Fatal Bleeding

Xarelto (rivaroxaban) is an anticoagulant drug (blood thinner) manufactured by Bayer and marketed by Johnson & Johnson’s Janssen Pharmaceuticals unit. Xarelto was approved by the FDA in July 2011 to reduce the risk of blood clots, deep vein thrombosis, and pulmonary embolism following knee or hip replacement surgery. Its approved uses were later expanded to include treatment of non-valvular atrial fibrillation and recurrence of deep vein thrombosis and of pulmonary embolism following the initial 6 months of treatment.

Since its approval, Xarelto has been linked to life-threatening bleeding events and deaths. The drug currently carries two “Black Box Warnings,” the FDA’s most serious type.

XARELTO BLACK BOX WARNINGS

Xarelto carries two “Black Box Warnings” on its label. The warnings state that:

  • Discontinuing Xarelto may increase the risk of dangerous blood clots and stroke in nonvalvular atrial fibrillation users; and,
  • Having spinal anesthesia, such as an epidural, or a spinal procedure, such as a spinal tap, may cause bleeding on or around the spine that can lead to paralysis, which may be permanent.

MORE THAN 100 DEATHS LINKED TO XARELTO

  • According to DrugCite.com, death was reported as an adverse effect of Xarelto in more than 100 patients.
  • The most common side-effect listed was pulmanry embolism (blood clot in the lungs).
  • The second and third most common side-effects were deep vein thrombosis (blood clots in the legs) and hemorrhage (major bleeding events).
XARELTO SIDE EFFECTS
  • Frequent nose bleeds
  • Uncontrollable bleeding
  • Unusual bleeding from the gums
  • Blood in stools or vomit
  • Coughing up blood or blood clots
  • Pulmonary embolism after hip or knee surgery
  • Unusual bruising or bleeding
  • Venous thrombosis events (VTE)
  • Cerebral hemorrhaging
  • Internal bleeding
  • Death

HAVE YOU BEEN INJURED?

If you’ve been injured, we can help. Contact us